Reinhard H. H. Neubert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reinhard H. H. Neubert has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Albert Härtl
Hans-Knöll-Institute for Natural Products Research , Beutenbergstraße 11a, 07745 Jena
2 shared publicationsBeate Bretschneider
Institute of Pharmaceutics and Biopharmaceutics, Department of Pharmacy, Martin-Luther-University Halle-Wittenberg , Wolfgang-Langenbeck-Str. 4, 06120 Halle
2 shared publicationsYahya Mrestani
Institute of Pharmaceutics and Biopharmaceutics, Department of Pharmacy, Martin-Luther-University Halle-Wittenberg, Wolfgang-Langenbeck-Str. 4, 06120 Halle, Germany
2 shared publicationsAndreas Pöppl
University Leipzig
1 shared publicationAnnett Krause
Department of Pharmacy, Institute of Pharmaceutics and Biopharmaceutics, Martin-Luther-University Halle-Wittenberg , 06120 Halle/Saale
1 shared publicationAnuj Shukla
Department of Physics, Optics Group, Martin-Luther-University Halle-Wittenberg, 06099 Halle/Saale, Germany
1 shared publication
Latest Publications
- 1 June 2006
- Published by Wiley in Electrophoresis
- Vol. 27 (12) , 2330-2337
Development of capillary electrophoresis methods for quantitative determination of taurine in vehicle system and biological media
- 1 June 2006
- Published by Wiley in Electrophoresis
- Vol. 27 (12) , 2330-2337
Development of capillary electrophoresis methods for quantitative determination of taurine in vehicle system and biological media
- 1 April 2005
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (4) , 423-427
Dermal delivery of desmopressin acetate using colloidal carrier systems
Recently, the transdermal route has received attention as a promising means to enhance the delivery of drug molecules, particularly peptides, across the skin. In this work, the skin penetration profiles of desmopressin acetate from a colloidal system (water-in-oil microemulsion) and an amphiphilic cream, a standard formulation, were determined using Franz diffusion cells and compared. In the case of the microemulsion, the total percentages of dose obtained from different skin layers (stratum corneum to subcutaneous tissue) were 3.30 ± 0.67, 7.37 ± 2.43 and 15.54 ± 2.72 at 30, 100 and 300 min, respectively. Similarly, 5.19 ± 0.96, 8.04 ± 0.97 and 14.4 ± 5.15% of the dose applied was extracted from the skin treated with the cream. About 6% of the applied dose reached the acceptor compartment from the microemulsion instead of 2% from the cream within 300 min. The concentration of drug that penetrated into the upper layers of the skin was higher from the cream than from the microemulsion at all time intervals. On the other hand, a higher amount of drug was found in the deeper skin layers and in the acceptor compartment from the microemulsion.
- 1 April 2005
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (4) , 423-427
Dermal delivery of desmopressin acetate using colloidal carrier systems
Recently, the transdermal route has received attention as a promising means to enhance the delivery of drug molecules, particularly peptides, across the skin. In this work, the skin penetration profiles of desmopressin acetate from a colloidal system (water-in-oil microemulsion) and an amphiphilic cream, a standard formulation, were determined using Franz diffusion cells and compared. In the case of the microemulsion, the total percentages of dose obtained from different skin layers (stratum corneum to subcutaneous tissue) were 3.30 ± 0.67, 7.37 ± 2.43 and 15.54 ± 2.72 at 30, 100 and 300 min, respectively. Similarly, 5.19 ± 0.96, 8.04 ± 0.97 and 14.4 ± 5.15% of the dose applied was extracted from the skin treated with the cream. About 6% of the applied dose reached the acceptor compartment from the microemulsion instead of 2% from the cream within 300 min. The concentration of drug that penetrated into the upper layers of the skin was higher from the cream than from the microemulsion at all time intervals. On the other hand, a higher amount of drug was found in the deeper skin layers and in the acceptor compartment from the microemulsion.
- 23 February 2005
- Published by Wiley in Chemie Ingenieur Technik
- Vol. 77 (3) , 239-243
Mikroemulsionen zur dermalen Applikation von Arzneistoffen
- 23 February 2005
- Published by Wiley in Chemie Ingenieur Technik
- Vol. 77 (3) , 239-243
Mikroemulsionen zur dermalen Applikation von Arzneistoffen
- 1 April 2004
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 56 (4) , 485-493
Influence of enhancers on the absorption and on the pharmacokinetics of cefodizime using in-vitro and in-vivo models
In the development of novel antibiotics, more and more compounds have been found that cannot be absorbed orally and, therefore, must be administered intravenously or intramuscularly. Because of the obvious drawbacks of drug delivery by injection, the development of alternatives with enhanced oral bioavailability has received much attention in pharmaceutical research. Cefodizime, a novel third-generation cephalosporin with significant advantages in the parenteral treatment of common infections, was used as a model drug. Cefodizime behaves as a highly hydrophilic compound, as shown from its extremely low partition coefficient. The effect of cationic absorption enhancers (hexadecyldimethyl-benzylammonium chloride, N-hexadecylpyridinium bromide, dodecyltrimethylammonium bromide and hexadecyltrimethylammonium bromide) on the lipophilicity of cefodizime was investigated by means of the n-octanol/water system. Results showed that the counter-ions had a positive influence on the solubility of cefodizime. These results on partitioning coefficients in the n-octanol/buffer system were confirmed using an in-vitro transport model with artificial and biological membranes (Caco-2-cells). Furthermore, the physiological compatibility of the absorption enhancers was investigated using the active d-glucose transport. The pharmacokinetic profile of cefodizime was evaluated in rabbits after intraduodenal administration with and without an absorption enhancer.
- 1 April 2004
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 56 (4) , 485-493
Influence of enhancers on the absorption and on the pharmacokinetics of cefodizime using in-vitro and in-vivo models
In the development of novel antibiotics, more and more compounds have been found that cannot be absorbed orally and, therefore, must be administered intravenously or intramuscularly. Because of the obvious drawbacks of drug delivery by injection, the development of alternatives with enhanced oral bioavailability has received much attention in pharmaceutical research. Cefodizime, a novel third-generation cephalosporin with significant advantages in the parenteral treatment of common infections, was used as a model drug. Cefodizime behaves as a highly hydrophilic compound, as shown from its extremely low partition coefficient. The effect of cationic absorption enhancers (hexadecyldimethyl-benzylammonium chloride, N-hexadecylpyridinium bromide, dodecyltrimethylammonium bromide and hexadecyltrimethylammonium bromide) on the lipophilicity of cefodizime was investigated by means of the n-octanol/water system. Results showed that the counter-ions had a positive influence on the solubility of cefodizime. These results on partitioning coefficients in the n-octanol/buffer system were confirmed using an in-vitro transport model with artificial and biological membranes (Caco-2-cells). Furthermore, the physiological compatibility of the absorption enhancers was investigated using the active d-glucose transport. The pharmacokinetic profile of cefodizime was evaluated in rabbits after intraduodenal administration with and without an absorption enhancer.
- 1 December 2003
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 55 (12) , 1601-1606
In-vitro and in-vivo studies of cefpirom using bile salts as absorption enhancers
Cephalosporins have to be administered by injection because of the poor intestinal absorption of the orally delivered drugs. Because of the obvious drawbacks of drug delivery by injection, the development of alternatives with enhanced oral bioavailability is receiving much attention in pharmaceutical research. Cefpirom (Cp) is a new semi-synthetic amino-2-thiazolyl-methoxyimino cephalosporin that has been substituted in position 3 with a cyclopenteno-pyridinium group in order to create a zwitterionic compound. It exhibits highly hydrophilic properties, as shown from its extremely low partition coefficient, and therefore its lipophilicity was increased using bile salts. The effect of this on the partition coefficients determined in the n-octanol/buffer system was confirmed using an in-vitro transport model with artificial and biological membranes. The pharmacokinetic properties of Cp were investigated in rabbits after intraduodenal administration with and without bile salts. Furthermore, the physiological compatibility of the bile salts was investigated using active D-glucose transport.
- 1 December 2003
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 55 (12) , 1601-1606
In-vitro and in-vivo studies of cefpirom using bile salts as absorption enhancers
Cephalosporins have to be administered by injection because of the poor intestinal absorption of the orally delivered drugs. Because of the obvious drawbacks of drug delivery by injection, the development of alternatives with enhanced oral bioavailability is receiving much attention in pharmaceutical research. Cefpirom (Cp) is a new semi-synthetic amino-2-thiazolyl-methoxyimino cephalosporin that has been substituted in position 3 with a cyclopenteno-pyridinium group in order to create a zwitterionic compound. It exhibits highly hydrophilic properties, as shown from its extremely low partition coefficient, and therefore its lipophilicity was increased using bile salts. The effect of this on the partition coefficients determined in the n-octanol/buffer system was confirmed using an in-vitro transport model with artificial and biological membranes. The pharmacokinetic properties of Cp were investigated in rabbits after intraduodenal administration with and without bile salts. Furthermore, the physiological compatibility of the bile salts was investigated using active D-glucose transport.
- 1 June 2003
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 55 (6) , 741-748
Microemulsions as colloidal vehicle systems for dermal drug delivery. Part IV: investigation of microemulsion systems based on a eutectic mixture of lidocaine and prilocaine as the colloidal phase by dynamic light scattering
Stable oil-in-water (o/w) microemulsions used as vehicles for dermal drug delivery have been developed using lidocaine (lignocaine) and prilocaine in oil form (eutectic mixture), a blend of a high (Tween 80, hydrophilic-lipophilic balance (HLB) = 15.0) and a low (Poloxamer 331, HLB = 1.0) HLB surfactant and propylene glycol-water as hydrophilic phase. These microemulsions were able to solubilize up to 20% eutectic mixture of lidocaine and prilocaine without phase separation. The dispersity of the oil phase was investigated by dynamic light scattering. Small colloidal droplets for stable microemulsions of 5∼10 nm were observed. At constant surfactant and hydrophilic phase concentration, increasing the total drug concentration in the microemulsion resulted in an increase in the droplet size of the dispersed, colloidal phase. It was observed that a monolayer of surfactant surrounds the oil (eutectic mixture) core. Colloidal droplets of the microemulsion interact via hard sphere with supplementary attractive interaction. This observed interparticle attractive interaction could explain the observed phase behaviour with respect to change in the basicity of the hydrophilic phase as well as the increase in volume fraction of the dispersed, colloidal phase. It was also observed that the stability and size of this dispersed phase depends on the pH of the composition. Because these microemulsions formed stable, isotropic systems in the range of pH 9.5 to 10.4 with alkali buffer or NaOH solution instead of water as hydrophilic phase, so one can produce microemulsions in this pH area.
- 1 June 2003
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 55 (6) , 741-748
Microemulsions as colloidal vehicle systems for dermal drug delivery. Part IV: investigation of microemulsion systems based on a eutectic mixture of lidocaine and prilocaine as the colloidal phase by dynamic light scattering
Stable oil-in-water (o/w) microemulsions used as vehicles for dermal drug delivery have been developed using lidocaine (lignocaine) and prilocaine in oil form (eutectic mixture), a blend of a high (Tween 80, hydrophilic-lipophilic balance (HLB) = 15.0) and a low (Poloxamer 331, HLB = 1.0) HLB surfactant and propylene glycol-water as hydrophilic phase. These microemulsions were able to solubilize up to 20% eutectic mixture of lidocaine and prilocaine without phase separation. The dispersity of the oil phase was investigated by dynamic light scattering. Small colloidal droplets for stable microemulsions of 5∼10 nm were observed. At constant surfactant and hydrophilic phase concentration, increasing the total drug concentration in the microemulsion resulted in an increase in the droplet size of the dispersed, colloidal phase. It was observed that a monolayer of surfactant surrounds the oil (eutectic mixture) core. Colloidal droplets of the microemulsion interact via hard sphere with supplementary attractive interaction. This observed interparticle attractive interaction could explain the observed phase behaviour with respect to change in the basicity of the hydrophilic phase as well as the increase in volume fraction of the dispersed, colloidal phase. It was also observed that the stability and size of this dispersed phase depends on the pH of the composition. Because these microemulsions formed stable, isotropic systems in the range of pH 9.5 to 10.4 with alkali buffer or NaOH solution instead of water as hydrophilic phase, so one can produce microemulsions in this pH area.
- 1 July 2002
- Published by Springer Nature in Pharmaceutical Research
- Vol. 19 (7) , 982-990
Role of Ascorbic Acid in Stratum Corneum Lipid Models Exposed to UV Irradiation
Purpose. The effects of ascorbic acid on Stratum corneum lipid models following ultraviolet irradiation were studied adding iron ions as transition metal catalysts. Methods.Lipid peroxidation was...
- 1 July 2002
- Published by Springer Nature in Pharmaceutical Research
- Vol. 19 (7) , 982-990
Role of Ascorbic Acid in Stratum Corneum Lipid Models Exposed to UV Irradiation
Purpose. The effects of ascorbic acid on Stratum corneum lipid models following ultraviolet irradiation were studied adding iron ions as transition metal catalysts. Methods.Lipid peroxidation was...
- 1 September 1998
- Published by Wiley in Electrophoresis
- Vol. 19 (12) , 2145-2150
Characterization of micelles by capillary electrophoresis
- 1 September 1998
- Published by Wiley in Electrophoresis
- Vol. 19 (12) , 2145-2150
Characterization of micelles by capillary electrophoresis